首页>投融资
Debut Biotechnology
B轮(B2)
Debut Biotechnology Inc is a biotechnology company.In June 2023, Debut Biotechnology Inc announced that it has raised $34M Series B funding round led by its investors
基本信息
-
公司全称Debut Biotechnology Inc
-
类型生物活性成分研发商
-
产业领域生物/化学技术、研发制造服务、原料药
-
公司人数51~100人
-
地址11545 Sorrento Valley Rd Suite 310 SAN DIEGO CALIFORNIA 92121; US; Telephone: +16194325177;
-
联系电话619.432.5177
-
邮箱Joshua@DebutBiotech.com
-
成立时间2019-05-16
投融资
-
2023-10-19B轮(B2)4000万美元Business Opportunities for L'Oréal Development
-
2023-06-02B轮(B1)3400万美元Fine Structure VenturesACVCMaterial ImpactGS FuturesBold Capital Group
-
2021-08-12A轮2260万美元ACVCFine Structure VenturesMaterial ImpactCantos VenturesKdT VenturesHumboldt Fund
-
2020-09-15未公开100万美元Air Force Research Laboratory
-
2020-01-07种子轮260万美元FTW VenturesSpringTide VenturesKdT VenturesBetter Ventures
- 加载更多
相关投融资企业
B轮(B2)
Debut Biotechnology Inc is a biotechnology company.In June 2023, Debut Biotechnology Inc announced that it has raised $34M Series B funding round led by its investors
B轮(B1)
Debut Biotechnology Inc is a biotechnology company.In June 2023, Debut Biotechnology Inc announced that it has raised $34M Series B funding round led by its investors
A轮
Debut Biotechnology Inc is a biotechnology company.In June 2023, Debut Biotechnology Inc announced that it has raised $34M Series B funding round led by its investors
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息